Compare Immunovant Inc. Common Stock (IMVT) vs James Hardie Industries plc. Ordinary Shares (JHX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs James Hardie Industries plc. Ordinary Shares — how do they compare? Immunovant Inc. Common Stock trades at $30.5 (market cap $6.25B), while James Hardie Industries plc. Ordinary Shares trades at $25.06 (market cap $14.60B). The key difference: James Hardie Industries plc. Ordinary Shares is far larger — about 2.3× Immunovant Inc. Common Stock's market cap, and James Hardie Industries plc. Ordinary Shares is more actively traded (7,262,924 versus 1,755,411). Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 1 Days and James Hardie Industries plc. Ordinary Shares for 1 Days on average.
| IMVT | JHX | |
|---|---|---|
Market Cap | $6.25B | $14.60B |
Volume | 1,755,411 | 7,262,924 |
Sector | Health | Basic Materials |
52-Week High | $44.96 | $31.08 |
52-Week Low | $17.03 | $16.69 |
Typical Hold Time | 1 Days | 1 Days |
Enterprise Value | $5.35B | $18.83B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About James Hardie Industries plc. Ordinary Shares
James Hardie manufactures fiber cement products for residential and commercial construction. Its portfolio includes exterior siding, interior boards, and other building materials.
Read more on JHX →
